Pharma News

Epigenic secures $60m financing to advance preclinical assets

Senhwa Biosciences CX-5461 Secures NCI Support to Advance into MYC-Driven Lymphoma, Driving Cross-Cancer and Global Licensing Value

FDA Grants Breakthrough Therapy Designation to Olomorasib With Pembrolizumab for NSCLC

Clene Inc. announces preclinical data showing CNM-Au8 enhances cellular health in Parkinson’s disease models, supporting further clinical development

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

Lupin's Aurangabad-based facility gets two observations from US FDA

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting

Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting

Amgen to invest $600m in new US science and innovation hub

Recall Alert: Popular Supplement for Men Swapped for Erectile Dysfunction Drug

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous (IV) phase.

CapVest to buy control of generics giant Stada in €10bn deal